IC2030: early insights from our call for innovations

Woman in pink print sari smiles at the infant daughter she holds in her arms.

Many of the technologies and interventions we received from our Innovation Countdown 2030 (IC2030) initiative survey focused on maternal and childhood needs. Photo: PATH/Gabe Bienczycki.

Last summer, we challenged experts from around the world to imagine the year 2030 with us

Cover of Innovation Matters.

“Innovation Matters” features articles from global leaders exploring the critical role innovation can play in accelerating solutions to the world’s most urgent health challenges.

The purpose? To identify and dramatically accelerate progress toward solving the world’s most urgent health issues by 2030.

Imagine the impact we’d have by engaging a cross-section of people from around the world to identify these innovations and coordinate investment early on. How many more lives could we save over the next 15 years?

We surveyed thousands of health experts and thought leaders, including technology developers and industry players, and crowdsourced ideas from around the world via social media.

We received hundreds of innovations

Many focused on maternal, child, and neonatal health issues, as well as health delivery systems. Examples included: heat-stable uterotonics to address postpartum hemorrhage, malaria vaccine candidates, rats specially trained to recognize the scent of tuberculosis in sputum samples, health care workforce training tools, vital data collection systems, and rapid diagnostics to detect multiple diseases.

Responses came from around the world

We received over 500 submissions from a wide range of entrepreneurs, academics, investors, and donors representing 33 countries. In fact, 27% of innovations came from low- and middle-income countries—such as Brazil, India, Kenya, and Vietnam—signifying their growing role in global health innovation.

Claudia Harner-Jay.

Claudia Harner-Jay, is a senior commercialization officer at PATH. Photo: PATH.

Nongovernmental organizations (37%), industry (28%), and academia (24%), provided the majority of innovation submissions. Some participants submitted their own innovation ideas while many nominated innovations developed by others.

The next steps in our innovation countdown

There’s much more to do. We’re working with over 50 experts to assess which ideas show the most promise and potential for impact. From the many innovations that were received, they will identify a final set of 20 to 30 promising health technologies and interventions that we’ll feature in the Innovation Countdown 2030 report, later in 2015.

To learn more and follow our progress, visit the IC2030 website.

Our guest contributor is Claudia Harner-Jay, senior commercialization officer in the Devices and Tools program at PATH.